Rolling Circle Amplification for Genetic Editing Efficiency

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for determining the efficiency and specificity of genetic-editing procedures are cumbersome, requiring specialized equipment and lengthy processes, such as PCR and sequencing, which are costly and time-consuming, while simpler denaturation-based methods lack accuracy and information content.

Innovation Solution

The use of Rolling Circle Amplification (RCA) to generate RCA-Products from genetic-editing samples, allowing for digital quantification and precise determination of editing efficiency without the need for specialized instrumentation, using labeled probes for differential detection and analysis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If PCR-based methods (Sanger sequencing, NGS, ddPCR) are used to determine genetic-editing efficiency, then measurement precision is improved, but device complexity and cost increase

Engineering Contradiction:
Improveediting efficiency measurement accuracyVSAvoidspecialized equipment requirements
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent replaces complex mechanical/instrumental systems (PCR machines, sequencers, droplet generators) with a simple optical detection system. The core substitution is replacing the mechanical amplification and detection machinery with a cell-based biosensor system that uses biological components (engineered cells expressing reporter genes) to directly report editing efficiency through optical signals that can be measured with standard microscopy or flow cytometry equipment.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces engineered cells as intermediary biosensors that mediate between the genetic-editing reaction and the detection system. These cells contain reporter genes (such as GFP or other fluorescent proteins) whose expression levels directly correlate with editing efficiency, allowing indirect but accurate measurement without requiring direct analysis of the edited DNA sequences.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If sequencing-based methods (Sanger, NGS) are used to determine genetic-editing efficiency, then measurement precision is improved, but loss of time increases

Engineering Contradiction:
Improveediting efficiency measurement accuracyVSAvoidanalysis time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent performs preliminary action by pre-engineering cells with reporter genes that are constitutively expressed or inducibly expressed in response to editing events. This preliminary setup allows for real-time or near-real-time detection of editing efficiency without requiring subsequent sequencing steps, as the cells continuously report their editing status through their optical properties.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent substitutes the time-consuming sequencing process with rapid optical detection. Instead of extracting DNA, amplifying it through multiple PCR cycles, and sequencing it over days, the system uses live cells that emit optical signals detectable within minutes to hours, dramatically reducing the time required while maintaining measurement precision.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Device complexity

If denaturation-based methods (T7 Endonuclease I, Surveyor) are used to determine genetic-editing efficiency, then device complexity is reduced, but measurement precision deteriorates

Engineering Contradiction:
Improveequipment requirementsVSAvoidediting efficiency measurement accuracy
Core Design Contradiction:
Device complexityVSMeasurement precision

Solution Approach 1:

The patent uses engineered cells as intermediary biosensors that provide quantitative information about editing efficiency. These cells serve as a bridge between the simple optical detection system and the complex molecular events of genetic editing, translating editing outcomes into measurable optical signals with high precision while requiring only simple equipment.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the detection parameter from direct DNA sequence analysis (which requires complex instrumentation) to optical property measurement (fluorescence intensity, cell sorting parameters) which can be measured with simple equipment. By transforming the editing efficiency information into optical signals through the cell-based reporter system, the patent achieves high measurement precision using only basic laboratory equipment.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach provides a rapid, accurate, and cost-effective method for determining genetic-editing efficiency and specificity, reducing analysis time from days to hours, with high sensitivity and specificity, using standard laboratory equipment.

Implementation Method 1

performing Rolling Circle Amplification, to generate RCA-Products from the one or more polynucleotide sequences in the sample

Methodology Applied
Scientific EffectRolling Circle Amplification:

Data Source

PatentUS20240158842A1Methods and uses for determining the efficiency of genetic-editing procedures
Publication Date: 2024.05.16 CONTAGEN AB
  • US20240158842A1 patent drawing
  • US20240158842A1 patent drawing
  • US20240158842A1 patent drawing

AI summary

The invention relates to methods and uses for determining the efficiency of a genetic editing procedure comprising the steps of: (i) providing a sample from a genetic-editing procedure, the sample comprising one or more correctly-edited polynucleotide sequence and/or one or more unedited polynucleotide sequence; (ii) performing Rolling Circle Amplification, to generate RCA-Products from the one or more polynucleotide sequences in the sample; and (iii) determining the efficiency of the genetic-editing procedure based on the presence of the RCA-Products generated in step (ii).